← All reportsView on Symbol
RLAY

RLAY

Medium conviction

Relay Therapeutics, Inc.

Healthcare · NASDAQ

$3.4B mkt cap

Brief updated Jul 9, 2026

Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions. T

Decifer Research·Data summary

RLAY is a medium-conviction name in Healthcare

RLAY sits at the intersection of key themes currently active in the market. The scoring engine rates it medium based on how well the active market forces line up with its business, plus available fundamental data. Financial metrics and analyst consensus provide additional context.

Why now

The market forces active right now are aligned with the company's core business exposure. The timing reflects the intersection of theme strength and available catalyst data.

Key risks

Data availability limits full scoring across all dimensions. Market forces can reverse rapidly; theme exposure does not guarantee the price follows. Fundamental valuation data may not reflect the most recent quarterly results.

What to watch

Monitor conviction score changes, especially the macro and analyst dimensions. Earnings guidance updates and analyst consensus shifts are the primary near-term catalysts.

59Medium conviction Conviction
macro
0/25
analyst
22/38
momentum
20/20
forward catalyst
4/15
valuation
15/23
highs
3/12
news catalyst
0/12
options flow
0/12
peer network
0/8
counter thesis
0/3
Key financials
Revenue growth (YoY)-5714.0%
Gross margin-54617.0%
Operating margin-2777.0%
Net margin-2554.0%
P/E ratio-13.0x
Return on equity-4394.0%
FCF yield-618.0%
Debt / equity0.0x
EV / sales307.4x
Valuation
Analyst consensusBUY
DCF fair value$-1
Next EPS estimate$-0.39
Macro context

'Iran Plans to Make Billions in Fees From Reopening the Strait of Hormuz' - Wall Street Journal

Iran plans to charge billions in fees for reopening the Strait of Hormuz, a critical oil shipping route, which could significantly impact global oil prices and increase geopolitical tensions in the region.

Jun 25, 2026

'Ship attacked in Strait of Hormuz as Iran threatens U.N.-backed route' - Washington Post

A ship was attacked in the Strait of Hormuz, a critical oil shipping route, as Iran threatens the U.N.-backed passage, potentially disrupting global oil supplies and escalating geopolitical tensions in the region.

Jun 25, 2026

International Maritime Organization Pauses Evacuations Following Ship Attack In Strait Of Hormuz

The International Maritime Organization has paused evacuations following a ship attack in the Strait of Hormuz, a critical oil shipping route, which could disrupt global oil supplies and increase geopolitical tensions.

Jun 25, 2026

Iran's Persian Gulf Authority Announces In X Post That Any Ships Transiting The Strait Of Hormuz Outside Designated Lanes By PGSA Will Not Be Covered By Safe Passage Guarantee

Iran's Persian Gulf Authority has announced that ships transiting the Strait of Hormuz outside designated lanes will not be covered by a safe passage guarantee, escalating tensions in the region and potentially disrupting global oil supplies. This move could lead to increased risk of conflict and higher oil prices.

Jun 25, 2026

Analyst intelligence
14 Buy0 Hold0 Sell
Earnings intelligence

Earnings surprises

-17.1%

2026-05

+15.8%

2026-02

-10.3%

2025-11

+16.3%

2025-08

+8.0%

2025-05

Generated Thu, 09 Jul 2026 05:00:08 GMT by Decifer intelligence engine. For informational purposes only — not investment advice. Decifer Intelligence Hub.